MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Yourgene Health wins UK framework contract for Covid-19 testing

StockMarketWire.com

Diagnostics company Yourgene Health said it had been awarded a framework agreement in the UK for its Covid-19 testing capabilities.

The agreement was awarded under Public Health England's National Microbiology Framework, for Yourgene's Clarigene SARS-CoV-2 assay and Manchester-based Covid testing service.

Lot 1 was the first of four to be announced and covered the supply of in-vitro diagnostic medical devices and associated services.

The term of the framework agreement for Lot 1 -- and each subsequent lot, if awarded -- was for an initial two years with options to extend by up to a further two years.

'Yourgene considers that the successful framework award, for which there was a competitive tender process, lends significant credibility to the Clarigene product and to the ompany's Covid testing services,' chief executive Lyn Rees said.

'More broadly, we expect the award to support business development outside the scope of this agreement with a growing network of commercial partners, addressing privately funded testing in healthcare and workplace settings.'

At 9:35am: (LON:YGEN) share price was 0p at 16.75p


Story provided by StockMarketWire.com